Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Part of paid clinical trials in Hollywood, Florida.
- Sponsor
- Atea Pharmaceuticals, Inc.
- Study ID
- NCT07314346
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Healthy Volunteer Study
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Buprenorphine/Naloxone + BEM/RZR — DRUGDay -5 to Day -1:buprenorphine/naloxone as individualized QD doses up to 24mg/6mg. Day 1 to Day 5:Individualized QD doses of buprenorphine/naloxone. Day 6 to Day 12:Individualized QD doses of buprenorphine/naloxone + BEM 550mg/RZR 180mg QD. Day 13 Individualized QD doses of buprenorphine/naloxone.
- Methadone +BEM/RZR — DRUGDay -5 to Day -1:methadone individualized QD doses: 30-150mg. Day 1 to Day 5:Individualized QD does of methadone. Day 6 to Day 12:Individualized QD doses of methadone + BEM 550mg/RZR 180mg QD. Day 13 Individualized QD doses of methadone.
Study Details
Drug-drug interaction study between Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Key Dates
- Start date
- Jan 7, 2025
- Status verified
- Dec 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 32 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: (n=16) buprenorphine/naloxone + BEM/RZR
- Experimental: (n=16) methadone + BEM/RZR
Primary Outcome Measure
Effect of BEM/RZR on PK of buprenorphine,norbuprenorphine and naloxone [ Time Frame: Day -5 to Day 13 ]
Central Contacts
- Atea Study Clinical Trials Administrator888-481-1607
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Atea Study Site | Hollywood | Florida | 33019 | |
| Atea Study Site | Overland Park | Kansas | 66212 | |
| Atea Study Site | Marlton | New Jersey | 08053 |
Find similar trials in Hollywood, FL
Related Studies
- Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic FunctionPHASE1 · Recruiting · Atea Pharmaceuticals, Inc. · Orlando, Florida
- Near-InfraRed Spectroscopy of Auricular StimulationRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control NeuroinflammationPHASE1 · Recruiting · General Biophysics LLC · Boston, Massachusetts
- The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This ResponseEARLY_PHASE1 · Recruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts